[HTML][HTML] Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer

H Luo, J Shan, H Zhang, G Song, Q Li, CX Xu - Seminars in Cancer Biology, 2022 - Elsevier
Dysregulation of the epigenetic processes, such as DNA methylation, histone modifications,
and modulation of chromatin states, drives aberrant transcription that promotes initiation and …

YAP1 expression is associated with survival and immunosuppression in small cell lung cancer

P Chen, C Sun, H Wang, W Zhao, Y Wu, H Guo… - Cell Death & …, 2023 - nature.com
Immunotherapy is considered a major breakthrough in the treatment of small cell lung
cancer (SCLC), although its anti-tumor efficacy is limited. With a high degree of malignancy …

Repression of linc01555 up-regulates angiomotin-p130 via the microRNA-122-5p/clic1 axis to impact vasculogenic mimicry-mediated chemotherapy resistance in …

D Li, YW Shen, H Ren, L Wang, J Yang, Y Wang - Cell Cycle, 2023 - Taylor & Francis
Long non-coding ribonucleic acid 01555 (linc01555) is a brand-new long non-coding RNA
(lncRNA) that acts a carcinogenic function in various cancers. However, its role in small cell …

[HTML][HTML] Lymphocyte activation gene-3 is associated with programmed death-ligand 1 and programmed cell death protein 1 in small cell lung cancer

H Sun, J Dai, L Zhao, J Zhu, H Wang… - Annals of …, 2021 - ncbi.nlm.nih.gov
Background In recent years, immunotherapy has achieved notable success in cancer
treatment. Indeed, the novel immune checkpoint lymphocyte activation gene-3 (LAG3) has …

[HTML][HTML] An ultrasound-derived stroke risk score to identify patients at high risk of stroke

Y Li, S Zheng, J Zhang, F Wang, X Liu… - Annals of Translational …, 2021 - ncbi.nlm.nih.gov
Background To develop an ultrasound-derived stroke risk (USR) score combining plaque
stiffness, surface morphology and lumen narrowing to evaluate the risk of stroke in patients …

Interrogating the Small-cell Lung Cancer Methylome using Liquid Biopsies

SU Haq - 2021 - search.proquest.com
Small cell lung cancer (SCLC) is one of the most aggressive types of cancers. Despite being
initially responsive to treatment, most patients relapse. Currently it is not clear how such …